The conjunctiva is a common site for the allergic inflammatory response due to it being highly vascularized, having constant exposure to environmental pollutants and allergenic pollens and having a unique conjunctival associated lymphoid tissue. The primary morbidity of anterior surface conjunctival disorders that include allergic conjunctivitis and tear film disorders is associated with its high frequency of involvement rather than its severity, although the more chronic forms can involve the cornea and lead to sight-threatening conditions. Ocular allergy is associated with IgE-mediated mast cell activation in conjunctival tissue leading to the release of pre- The allergic events during AC occur following exposure to allergens mainly pollens, animal dander, and mold spores. Mast cell activation takes place in two phases: an acute phase, occurring within minutes, and a late phase, spanning from 6 to 72 h after exposure. The acute-phase reaction is due to the release of preformed (e.g,
histamine) and inducible mediators after the cross-linking of allergenspecific IgE on the surface of resident MCs. 5, 6 The late-phase reaction is characterized by the release of chemokines including CCL11, CCL24, CCL5, monocyte chemoattractant protein-3 (MCP-3,CCL7), CCL13, and macrophage inflammatory protein 1a (MIP-1a,CCL3) and the infiltration of eosinophils, basophils, T cells, neutrophils, and macrophages that generate a spectrum of other mediators adding to conjunctival inflammation. 5 ( Figure 1A ) In addition to histamine, tryptase and other proteases, arachidonic acid metabolites (leukotrienes, prostaglandins), cytokines, chemokines, growth factors, and adhesion molecules participate in the pathogenesis of the allergic inflammation of the ocular surface. 7 Acute ocular allergy symptoms include itching, tearing, and swelling and with unchecked ongoing chronic ocular inflammation from eosinophils and Th2-generated cytokines on the ocular surface there is increase potential impact on the visual axis. 4, 8 The tear film that blankets the ocular surface improves refraction, lubrication, nutrient delivery, and protection to the epithelial surface.
The tear fluid contains specific inflammatory markers including his- Cross-linking the receptors by allergen results in MC degranulation and a broad spectrum of cytokines and mediators are released. TNF-a induces the IL-8 release from conjunctival epithelial cells and fibroblasts which acts through CXCR1 and CXCR2 to make neutrophils infiltrate conjunctiva. Additionally, IL-4 induces Eotaxin-1(CCL11) release from fibroblasts and contribute to eosinophil infiltration by acting through CCR3. DCs upregulate CCR7 in response to CCL21 after antigen uptake and migrate to the ocular lymph nodes to activate T cells 18, 19 ; for instance, MIP-1a-CCR1 interaction is required for the immediate hypersensitivity reaction and MC activation and CCL11-CCR3 interaction is needed for activation and homing signal for eosinophils. 18 Experimental allergic conjunctivitis initiated in wildtype and CCR3 -/-mice by passive transfer of ragweed (RW)-specific IgE, followed by topical challenge with RW in eye drops showed that CCR3 is associated with both the early-phase reaction and latephase inflammation during ocular allergy. 20 Ag-specific TH2 cells contribute to conjunctival eosinophil infiltration in severe types of AC such as vernal keratoconjunctivitis. 21 Moreover, it is hypothesized that infiltrating antigen-specific IL-4-producing Th2 cells activate fibroblasts to release eosinophil-attracting chemokines, including eotaxin. 17 CD4+, CD45+RO, and HLA-DR+ T cells have also been reported in conjunctiva of patients with atopic and vernal keratoconjunctivitis 22 ( Figure 2 ). Infectious conjunctivitis caused by viral and bacterial pathogens (mainly staphylococci bacteria and adenoviruses) may be distinguished from allergic disease by conducting a thorough history and physical examination since the former type typically causes ocular burning, foreign body sensation, stinging, discomfort with a "gummy" discharge commonly causing a glue eye, rather than itching. 26 The key symptoms in bacterial conjunctivitis include soreness of the eye and redness that is typically unilateral, with purulent discharge while key symptoms observed in viral conjunctivitis include mild discomfort typically bilaterally with watery and mucoid discharge. 27 Conjunctival swabs for the culture or polymerase chain reaction techniques may show infectious etiology in Infectious conjunctivitis.
Additionally, conjunctival cytology, if available, could be a practical tool in differential diagnosis of ocular allergies.
T A B L E 1 Classification of AC types according to clinical manifestations, course, and prognosis differences
Main features Ref

Seasonal allergic conjunctivitis (SAC)
Also called "hay fever" conjunctivitis, seasonal rhinoconjunctivitis or conjunctivorhinitis which are the most common form of disease. The onset coincides with regional seasonal increase in circulating allergens (tree pollens in early spring; grasses in May through July; and weed pollens and outdoor molds from August through October). Generally considered having mild to moderate morbidity, but it is not sight-threatening. Ocular pruritus is the predominant symptom with conjunctival hyperemia and with more chronicity of condition papillae in tarsal conjunctiva are observed.
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Perennial allergic conjunctivitis (PAC)
Persistent IgE-mediated degranulation of MCs prompts the recruitment of eosinophils.
Patients experience symptoms throughout the year (main difference with SAC). The symptoms arise from singular and/or multiple indoor allergens, such as animal dander, molds, and dust mites. PAC differs from SAC in that the persistent IgE-mediated degranulation of MCs prompts the recruitment of eosinophils, moreover, PAC tends toward chronicity because of the continued exposure to allergen throughout the year.
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Vernal keratoconjunctivitis (VKC)
VKC mainly affects children and young adolescents, often complicated by keratitis and corneal ulcers main symptoms include intense itching and photophobia. Signs include redness, lid swelling, inflammatory ptosis, ropy discharge, and eosinophilic granulomas associated with severe corneal involvement and visual loss. T cells and eosinophils predominate with a Th2 cytokine-driven inflammation.
It is particularly characterized by T cell-mediated responses and increased concentrations of conjunctival T cells. Cytotoxic proteins released from eosinophils infiltrating locally into the conjunctiva are thought to cause keratoconjunctival disorders such as severe AKC and VKC. The hallmark that differentiates VKC from other allergic conjunctivitis is the presence of limbal and giant cobblestone papillae on the upper tarsal conjunctiva. Corneal neovascularization with extensions of limbal vegetation affecting vision, shield ulcers, pseudogerontoxon, and keratoconus may occur in severe cases. It is bilateral chronic inflammatory disease of the ocular surface and eyelid. Pathomechanism involves both chronic IgE-mediated MC degranulation and immune mechanisms mediated by Th1-and Th2-lymphocyte derived cytokines. Eczematous lesions may be found on the eyelids. The disease is associated with severe corneal involvement and visual loss.
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Giant papillary conjunctivitis (GPC)
GPC is not considered as a true allergic condition but rather a chronic inflammatory disease. Hypersensitivity reaction typically caused by contact lens wear. It could be associated with ocular prostheses, postoperative sutures. GPC is characterized by a T cell-mediated response.
7 ELIEH ALI KOMI ET AL.
| 531
Follicular conjunctivitis is a common differential diagnostic eye disease that is asymptomatic or mild and may not require treatment. 3 Another pathologic condition, which may cause damage to the conjunctiva and corneal epithelium and predispose conjunctiva to infection, is Sj€ ogren's syndrome. The disease is an autoimmune disorder characterized by reduced lacrimal and salivary gland function and leads to the sicca complex (dry eyes and dry mouth). 27 Remodeling and/or structural destruction of the basement membrane scaffolding in salivary glands of these patients is attributed to matrix metallopeptidase-9 (MMP9). As MC-derived chymase can cause breakdown of extracellular matrix (ECM) and activation of MMP9 precursor, mast cells may play a role in pathogenesis of Sj€ ogren's syndrome. pruritus, and mucus hypersecretion through stimulating the goblet cell. 41 Additionally, preformed mediators predominantly are stored in mast cell granules (e.g, histamine, proteoglycans, tryptase, neutral serine proteases, chymase, and carboxypeptidase). 38 Chymase is a potent converter of angiotensin I to angiotensin II and the IL-1b precursor to its active form. 42 Moreover, it has been reported as a pharmacotherapeutic target for AC in animal model. 43 In an allergic conjunctivitis animal model, the application of a chymase inhibitor (ONO-WH-236), in a dose-dependent fashion, inhibited conjunctival edema and erythema. 42 Classically, the histamine H1 receptor has been the target of therapy for AC, but the H2 receptor is also involved in the development of vasodilation of the ocular surface.
Histamine binding to specific receptors results in increased release of IL-1b, IL-6, IL-8, IL-10, IL-11, eotaxin, and GM-CSF. 32 The contribution of H4 receptor in itching has been investigated using knockout mice that demonstrated fewer bouts of scratching when they were given a dose of histamine in comparison with wild-type ani- For the purpose of immunization and induction of experimental allergic conjunctivitis, they used single and multiple allergen exposures.
Single exposure was done by injecting ragweed pollen plus aluminum hydroxide in both types of mice. Conjunctivitis was induced by topical application of ragweed suspended in phosphate-buffered saline (PBS).
On day 22, symptoms including conjunctival edema, lid edema, tear discharge, and conjunctival redness were graded. It was revealed that the early-phase and eosinophilic responses were minimal in Kit w / Kit wÀv mice after sensitizing but were fully restored following adoptive transfer. 34 Fukuda et al, using a CCR3-/-mice model, investigated the role of CCR3 (expressed on eosinophils and MCs) in both the of conjunctional blood vessels. 47 Long-term use of the antihistamine antazoline and the vasoconstrictor naphazoline is not recommended because they both can cause rebound hyperemia. 48 Levocabastine hydrochloride is a selective histamine H1-receptor antihistamine which is used worldwide as a topical treatment for AC and allergic rhinitis. 49 Preservative-free levocabastine 0.05% ophthalmic solution has been reported effective in the prevention of allergic conjunctivitis induced by a conjunctival provocation test. indicated for the treatment of more severe chronic forms of ocular allergy having pannus formation or corneal ulcers associated with VKC and GPC. Interestingly, they have also been reported to improve nasal symptoms due to direct drainage onto the nasal mucosa through the nasolacrimal duct. 51 For optimum symptomatic relief, these group of agents need to be administered prior to exposure and may require up to 6 weeks to gain their full effect. 52 Nedocromil sodium, a pyranoquinoline dicarboxylic acid, is an antiinflammatory drug that had the unique effect of causing yellow stains on clothing, but similar to other cromolyn based agents requires multiple daily doses for maximum effect. 53 Lodoxamide, another mast cell stabilizer was reported to be approximately 2500 times more potent than cromolyn in the prevention of histamine release in animal models requiring multiple doses for effect. 54 It is the most effective drug for controlling the early-phase inflammatory process of VKC and alleviating severe vision disturbing signs and symptoms. and H4 receptor inverse agonism, inhibition of MC histamine release, decreased eosinophil chemotaxis and activation. 57 Ketotifen is an H1
antihistamine that also inhibits release of histamine and inflammatory mediators from MCs and eosinophils. It can prevent the infiltration, activation, and degranulation of eosinophils. Ketotifen is used in different conditions such as asthma, allergic rhinitis in addition to AC. 58 Ketotifen, which appears to have multiple actions, is distinguishing itself from other cromolyn compounds (e.g, sodium cromoglycate, nedocromil), by a conjoint mast cell stabilizing, and H1 receptor inverse agonism 59 as well as inhibition of leukotriene formation. 60 Olopatadine hydrochloride is a relatively selective histamine H1-receptor inverse agonist that possesses mast cell stabilizing features. 61 It is available in 3 formulations (0.1%, 0.2% and 0.7%). Olopatadine has demonstrated capable inhibition of various cytokines 62 including TNF-a. 63 It is active in the conjunctival allergen challenge model and has a rapid onset of action (within 20 min after instillation) and a duration of ≥8 h. 64 Topical multiple action agents appear to inhibit the effects of histamine as well as the synthesis of additional inflammatory mediators that accentuate the late-phase response of the anterior surface of the eye. Loteprednol has the unique claim of being a "site-specific" steroid, due to residing at the target tissue long enough to render a therapeutic effect but not long enough to cause the secondary harmful effects of, for example, raised IOP. 71, 72 Topical or systemic administered steroids will transiently produce an increase in IOP in susceptible individuals that is thought to be genetically influenced. IOP effects are consistent among the different esters of the same corticosteroid base that are not dependent on their efficacy. In general, steroids with low absorption (e.g, fluorometholone) should be used first with the dosing being based on the state of inflammation of the eye, and only when these are proven to be ineffective, should the more potent steroids (including prednisolone, dexamethasone, betamethasone) be employed. 
